Vertex and republic of ireland expand long-term cystic fibrosis medicines reimbursement agreement

Vertex and republic of ireland expand long-term cystic fibrosis medicines reimbursement agreement to include triple combination therapy for all eligible patients ages 12 and over once licensed.vertex pharmaceuticals - confirmed it negotiated an agreement with health service executive in republic of ireland.
VRTX Ratings Summary
VRTX Quant Ranking